Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 412 record(s)

Req # A-2021-001446

The complete list of medical cannabis research that Health Canada has been involved in since the enacting of the original Marihuana Medical Access Regularions (MMAR) legislation, through to November 26th, 2021.

Organization: Health Canada

1 page(s)
April 2022

Req # A-2021-001454

Most recent publicly available product labelling available from Health Canada including package insert, label and carton for Flon Laboratories Inc. Dehydrated Alcohol (DIN 00394394) and Hospira Healthcare ULC Dehydrated Alcohol (DIN 00537640).

Organization: Health Canada

13 page(s)
April 2022

Req # A-2021-001603

For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the cover letter from the drug sponsor.

Organization: Health Canada

0 page(s)
April 2022

Req # A-2021-001739

All records related to the Minister of Health's January 7, 2022 Public Briefing. Ensure that the January 6, 2022 Covid 19 B.1.1.529 Omicron Variant of Concern Response Placemat is included along with any other January 6, 2022 Covid 19 Variant…

Organization: Health Canada

0 page(s)
April 2022

Req # A-2021-001744

The brand name of the reference product and the dosage form of the generic submission under review for the combination of medicinal ingredients sulfamethoxazole and trimethoprim.

Organization: Health Canada

1 page(s)
April 2022

Req # A-2021-001775

All emails sent or received by Health Canada's deputy minister regarding the federal announcement made Jan.5, 2022 about providing 140 million rapid tests to provinces in January, from Dec.1, 2021 to January 13, 2022.

Organization: Health Canada

5 page(s)
April 2022

Req # A-2021-001833

Statements of work and all amendments for the following three contracts: HT399-202702, HT399-194691, HT399-204832. List of names of all subcontractors with dollar amounts paid.

Organization: Health Canada

85 page(s)
April 2022

Req # A-2021-001977

The Code of Conduct for Health Canada. The Code of Conduct for employees of the Public Service Occupational Health Program. The Code of Conduct for Occupational Health Medical Officers within the Public Service Occupational Health Program.

Organization: Health Canada

25 page(s)
April 2022

Req # A-2021-002003

The Canada Gazette, Part I, Volume 155, Number 25: Order Amending Schedules 2 and 3 to the Tobacco and Vaping Products Act (Flavours) REGULATORY IMPACT ANALYSIS STATEMENT refers to the elicitation of estimates of the risk of vaping compared to…

Organization: Health Canada

67 page(s)
April 2022

Req # A-2021-002004

Grants or other payments have Health Canada made to Physicians for a Smoke-Free Canada from Jan 1st, 2021 to Feb 24th, 2022. The purpose of each payment or grant. What did Health Canada receive in return for the payment or grant?

Organization: Health Canada

14 page(s)
April 2022
Date modified: